PulseNmore, the Israeli maker of a home ultrasound device for pregnant women, jumped about 200% on Thursday on both the Tel Aviv Stock Exchange and Nasdaq after announcing a strategic partnership with U.S. telehealth company Ouma. Ouma specializes in pregnancy support services, and the deal will integrate PulseNmore’s FDA-cleared home ultrasound technology, approved about five months ago, into Ouma’s virtual pregnancy care model across all 50 U.S. states.
The companies plan to roll out the device through collaborations with major insurers, health systems, OB-GYN groups and community health centers. The integration is designed to keep clinicians in regular contact with pregnant women throughout pregnancy and to deepen the clinical scope of remote monitoring. For PulseNmore, the agreement is also intended to provide a platform for expansion in the U.S. with additional insurers.
PulseNmore went public in Tel Aviv in 2021 at a valuation of $200 million during a wave of so-called dream-company IPOs that later disappointed investors. Its market value later fell to about $80 million, and about a year ago General Electric sold its stake, a move seen by the market as a sign of waning confidence. The company also listed on Nasdaq in January this year.
In its 2025 financial report, PulseNmore posted $12.5 million in revenue and a $5 million loss, and it hopes to reach operating break-even in the coming year. CEO Elazar Sonnenstein told ynet the partnership is a major leap, saying each U.S. state requires separate authorization for reading ultrasound results, while the Ouma deal gives the company a route into all 50 states without separate approval expenses. He also said about 35% of U.S. counties are “obstetric care deserts,” making remote care especially important. Ouma’s Dr. Sina Hari said the technology lets the company move much of prenatal care into the patient’s home while staying connected to a clinical team. In Israel, PulseNmore already works with Clalit Health Services, which provides tens of thousands of home pregnancy ultrasound devices. The company’s chairman is Yonatan Aderet, formerly chairman of Mazor Robotics.
